227 related articles for article (PubMed ID: 15550550)
1. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
[TBL] [Abstract][Full Text] [Related]
3. IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.
Roato I; Brunetti G; Gorassini E; Grano M; Colucci S; Bonello L; Buffoni L; Manfredi R; Ruffini E; Ottaviani D; Ciuffreda L; Mussa A; Ferracini R
PLoS One; 2006 Dec; 1(1):e124. PubMed ID: 17205128
[TBL] [Abstract][Full Text] [Related]
4. T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients.
Brunetti G; Colucci S; Pignataro P; Coricciati M; Mori G; Cirulli N; Zallone A; Grassi FR; Grano M
J Periodontol; 2005 Oct; 76(10):1675-80. PubMed ID: 16253089
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer.
Roato I; Gorassini E; Buffoni L; Lyberis P; Ruffini E; Bonello L; Baldi I; Ciuffreda L; Mussa A; Ferracini R
Lung Cancer; 2008 Jul; 61(1):109-16. PubMed ID: 18061306
[TBL] [Abstract][Full Text] [Related]
6. IL-7 modulates osteoclastogenesis in patients affected by solid tumors.
Roato I; Gorassini E; Brunetti G; Grano M; Ciuffreda L; Mussa A; Ferracini R
Ann N Y Acad Sci; 2007 Nov; 1117():377-84. PubMed ID: 17584976
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases in gastric cancer follow a RANKL-independent mechanism.
D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; De Giuli M; Sandrucci S; Ferracini R; Roato I
Oncol Rep; 2013 Apr; 29(4):1453-8. PubMed ID: 23404437
[TBL] [Abstract][Full Text] [Related]
8. Osteoclasts are active in bone forming metastases of prostate cancer patients.
Roato I; D'Amelio P; Gorassini E; Grimaldi A; Bonello L; Fiori C; Delsedime L; Tizzani A; De Libero A; Isaia G; Ferracini R
PLoS One; 2008; 3(11):e3627. PubMed ID: 18978943
[TBL] [Abstract][Full Text] [Related]
9. Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues.
Roato I; Caldo D; D'Amico L; D'Amelio P; Godio L; Patanè S; Astore F; Grappiolo G; Boggio M; Scagnelli R; Molfetta L; Ferracini R
Biomaterials; 2010 Oct; 31(29):7519-25. PubMed ID: 20638717
[TBL] [Abstract][Full Text] [Related]
10. In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
Vandooren B; Melis L; Veys EM; Tak PP; Baeten D
Arthritis Rheum; 2009 Apr; 60(4):1020-5. PubMed ID: 19333923
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
12. Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.
Roato I; Porta F; Mussa A; D'Amico L; Fiore L; Garelli D; Spada M; Ferracini R
PLoS One; 2010 Nov; 5(11):e14167. PubMed ID: 21152388
[TBL] [Abstract][Full Text] [Related]
13. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
14. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA
Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927
[TBL] [Abstract][Full Text] [Related]
15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
16. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
17. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
18. Relaxin stimulates osteoclast differentiation and activation.
Ferlin A; Pepe A; Facciolli A; Gianesello L; Foresta C
Bone; 2010 Feb; 46(2):504-13. PubMed ID: 19833242
[TBL] [Abstract][Full Text] [Related]
19. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.
Durand M; Boire G; Komarova SV; Dixon SJ; Sims SM; Harrison RE; Nabavi N; Maria O; Manolson MF; Mizianty M; Kurgan L; de Brum-Fernandes AJ
Bone; 2011 Mar; 48(3):588-96. PubMed ID: 20959150
[TBL] [Abstract][Full Text] [Related]
20. The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.
Brunetti G; Colucci S; Rizzi R; Mori G; Colaianni G; Oranger A; Zallone A; Liso V; Grano M
Ann N Y Acad Sci; 2006 Apr; 1068():334-40. PubMed ID: 16831934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
